this paper describes an open assessment of cinoxacin in the treatment of 30 outpatients with symptomatic urinary tract infections caused by escherichia coli , klebsiella , proteus mirabilis , and enterobacter .
C0008806
cinoxacin
C0042029
urinary tract infections